Janux Therapeutics Statistics

Total Valuation

JANX has a market cap or net worth of $2.73 billion. The enterprise value is $2.09 billion.

Market Cap	2.73B
Enterprise Value	2.09B

Important Dates

The last earnings date was Wednesday, November 6, 2024, after market close.

Earnings Date	Nov 6, 2024
Ex-Dividend Date	n/a

Share Statistics

JANX has 52.48 million shares outstanding. The number of shares has increased by 19.85% in one year.

Current Share Class	52.48M
Shares Outstanding	52.48M
Shares Change (YoY)	+19.85%
Shares Change (QoQ)	+0.33%
Owned by Insiders (%)	7.84%
Owned by Institutions (%)	74.42%
Float	38.00M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	204.06
Forward PS	n/a
PB Ratio	4.15
P/TBV Ratio	4.16
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	160.46
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 38.80, with a Debt / Equity ratio of 0.04.

Current Ratio	38.80
Quick Ratio	38.58
Debt / Equity	0.04
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -12.05% and return on invested capital (ROIC) is -10.20%.

Return on Equity (ROE)	-12.05%
Return on Assets (ROA)	-9.93%
Return on Capital (ROIC)	-10.20%
Revenue Per Employee	$203,891
Profits Per Employee	-$945,875
Employee Count	64
Asset Turnover	0.02
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +760.76% in the last 52 weeks. The beta is 3.52, so JANX's price volatility has been higher than the market average.

Beta (5Y)	3.52
52-Week Price Change	+760.76%
50-Day Moving Average	49.46
200-Day Moving Average	42.50
Relative Strength Index (RSI)	49.53
Average Volume (20 Days)	690,712

Short Selling Information

The latest short interest is 4.31 million, so 8.21% of the outstanding shares have been sold short.

Short Interest	4.31M
Short Previous Month	4.33M
Short % of Shares Out	8.21%
Short % of Float	11.34%
Short Ratio (days to cover)	6.66

Income Statement

In the last 12 months, JANX had revenue of $13.05 million and -$60.54 million in losses. Loss per share was -$1.19.

Revenue	13.05M
Gross Profit	-46.77M
Operating Income	-85.96M
Pretax Income	-44.05M
Net Income	-60.54M
EBITDA	-83.88M
EBIT	-85.96M
Loss Per Share	-$1.19

Full Income Statement

Balance Sheet

The company has $658.03 million in cash and $23.43 million in debt, giving a net cash position of $634.60 million or $12.09 per share.

Cash & Cash Equivalents	658.03M
Total Debt	23.43M
Net Cash	634.60M
Net Cash Per Share	$12.09
Equity (Book Value)	656.10M
Book Value Per Share	12.54
Working Capital	649.15M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$36.99 million and capital expenditures -$832,000, giving a free cash flow of -$37.82 million.

Operating Cash Flow	-36.99M
Capital Expenditures	-832,000
Free Cash Flow	-37.82M
FCF Per Share	-$0.72

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	-658.76%
Pretax Margin	-463.91%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	-315.63%

Dividends & Yields

JANX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-19.85%
Shareholder Yield	-19.85%
Earnings Yield	-2.22%
FCF Yield	-1.39%

Analyst Forecast

The average price target for JANX is $65.10, which is 25.22% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$65.10
Price Target Difference	25.22%
Analyst Consensus	Strong Buy
Analyst Count	10
Revenue Growth Forecast (5Y)	75.30%
EPS Growth Forecast (5Y)	11.62%

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

JANX has an Altman Z-Score of 24.19 and a Piotroski F-Score of 4.

Altman Z-Score	24.19
Piotroski F-Score	4